Dr. Diderichsen joined Certara in 2011 and currently leads Europe-Africa regional team within CDDS-QSS.

He holds a master’s degree in Applied Physics and a PhD in mechanism-based and data-driven modeling and simulation from the Technical University of Denmark. Prior to joining Certara, Dr. Diderichsen developed his modeling and simulation skillset at Novo Nordisk and Abbott.

At Certara, he has led and supported numerous consultancy engagements, applying model-informed drug development (MIDD) approaches to support study design, regulatory interactions and filings, and overall development strategy.

Dr. Diderichsen’s expertise covers the full range of MIDD methodologies including population PK, PK/PD, exposure–response, C-QTc, and model-based meta-analysis. He has provided MIDD support across a broad range of therapeutic areas, including oncology, immunology, and diabetes.